Esc Cardio Talk
ESC Congress 2019 - Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:09:47
- More information
Informações:
Synopsis
With Roxana Mehran, The Mount Sinai Hospital - USA, Jan Steffel, University Hospital Zurich - Switzerland & Diana Gorog, University of Hertfordshire - UK Link to paper:
